By Toni Weeks
San Luis Obispo, Calif., Feb. 20 - HSBC USA Inc. priced $2.69 million of 0% return enhanced notes due Feb. 15, 2017 linked to a basket of three equally weighted stocks, according to a 424B2 filing with the Securities and Exchange Commission.
The underlying companies are AstraZeneca plc, Bristol-Myers Squibb Co. and Merck & Co., Inc.
The payout at maturity will be par plus 1.8 times any gain in the basket.
Investors will be exposed to any losses.
The final basket level will be the average of the basket levels on five trading days ending Feb. 10, 2017.
HSBC Securities (USA) Inc. is the underwriter, and J.P. Morgan Securities LLC is the agent.
| Issuer: | HSBC USA Inc.
|
| Issue: | Return enhanced notes
|
| Underlying stocks: | AstraZeneca plc (Symbol: AZN), Bristol-Myers Squibb Co. (Symbol: BMY) and Merck & Co., Inc. (Symbol: MRK), equally weighted
|
| Amount: | $2.69 million
|
| Maturity: | Feb. 15, 2017
|
| Coupon: | 0%
|
| Price: | Par
|
| Payout at maturity: | If basket return is positive, par plus 1.8 times basket return; if basket return is negative, 1-to-1 exposure to decline
|
| Initial share prices: | $67.40 for AstraZeneca, $54.37 for Bristol-Myers and $55.44 for Merck
|
| Final basket level: | Average of basket's closing levels on five trading days ending Feb. 10, 2017
|
| Pricing date: | Feb. 14
|
| Settlement date: | Feb. 20
|
| Underwriter: | HSBC Securities (USA) Inc. with J.P. Morgan Securities LLC as agent
|
| Fees: | 2%
|
| Cusip: | 40432XTW1
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
